3177 results for «365»

Filter By

3177 results

Managing severe calcified LAD lesions in STEMI: Insights from three cases

04 Oct 2024 – From AICT-AsiaPCR 2024

Dive into this compelling presentation highlighting three challenging STEMI cases involving severe proximal LAD calcified stenosis. Witness the ingenuity of interventional strategies as the presenter explores how drug-coated balloons can be a viable alternative to stents in acute MI management. Don't miss this opportunity to deepen...

Managing severe calcified LAD lesions in STEMI: Insights from three cases

The turning point in hypertension care: renal denervation in practice

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore the latest advancements in hypertension care with this session on renal denervation. Stay up-to-date with the latest guidelines for hypertension treatment using renal denervation. Delve into the importance of patient selection and their preferences, and understand the key steps to perform a safe and effective...

The turning point in hypertension care: renal denervation in practice

Resorbable magnesium scaffolds - Unveiling the future

04 Oct 2024 – From AICT-AsiaPCR 2024

Explore the future of coronary interventions with this session on resorbable magnesium scaffolds (RMS). Understand the limitations of drug-eluting stents and the emerging role of resorbable scaffolds. Delve into the technology behind RMS, including the key features and degradation characteristics of the new generation Freesolve RMS....

Resorbable magnesium scaffolds - Unveiling the future

Latest paradigm changes in mechanical circulatory support for high-risk PCI and AMI cardiogenic shock

04 Oct 2024 – From AICT-AsiaPCR 2024

Stay at the forefront of mechanical circulatory support for high-risk PCI and AMI cardiogenic shock. This session will equip you with the knowledge to appropriately select patients for percutaneous ventricular assist device (PVAD) supported high-risk PCI. Dive into the latest clinical evidence on the use of...

Latest paradigm changes in mechanical circulatory support for high-risk PCI and AMI cardiogenic shock

TAVI for a patient with small aortic annulus

04 Oct 2024 – From AICT-AsiaPCR 2024

Join us for a LIVE educational case from the National University Heart Centre, Singapore, focusing on the challenges of TAVI in patients with small aortic annuli. Gain insights into strategies for valve selection, deployment techniques, and overcoming anatomical constraints to deliver optimal outcomes for this complex...

TAVI for a patient with small aortic annulus

How to treat complex calcified lesions

04 Oct 2024 – From AICT-AsiaPCR 2024

Dive into the complex world of treating calcified lesions, where imaging guidance and specialized techniques are crucial. Discover strategies for tackling challenging cases, from calcified left main bifurcations to multivessel disease with severe left ventricular dysfunction. Learn how to leverage imaging insights, calcified modification techniques, and...

How to treat complex calcified lesions

Best clinical cases: Stent degloving, valve defects, and calcified lesions

04 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in a captivating collection of best clinical cases from AICT-AsiaPCR 2024. Witness the ingenuity and expertise of interventional cardiologists as they navigate complex scenarios, from addressing stuck prosthetic mitral valves to managing unconventional calcified lesions. Discover unique approaches, innovative solutions, and valuable lessons that...

Best clinical cases: Stent degloving, valve defects, and calcified lesions

Complex NSTEMI interventions: Bifurcation and calcification management strategies

05 Oct 2024 – From AICT-AsiaPCR 2024

Explore a diverse array of challenging NSTEMI cases in this session, curated from the AICT-AsiaPCR 2024 conference. Witness innovative approaches to managing bifurcation lesions, tackling calcified and complex coronary anatomy, and navigating double complications. Gain valuable insights from experienced interventionalists as they share their strategies for...

Complex NSTEMI interventions: Bifurcation and calcification management strategies

Tricuspid and other interventions for valvular disease

05 Oct 2024 – From AICT-AsiaPCR 2024

Immerse yourself in this captivating session featuring selected clinical case submissions from the AICT-AsiaPCR 2024 conference. Explore a wide range of interventional challenges, including device closure of ruptured sinus of Valsalva aneurysm, balloon valvotomy during pregnancy in a double orifice mitral valve, and unusual femoral complications....

Tricuspid and other interventions for valvular disease

Intriguing cases in interventional cardiology

05 Oct 2024 – From AICT-AsiaPCR 2024

Delve into a diverse array of intriguing cardiology cases submitted to the AICT-AsiaPCR 2024 conference. Explore scenarios ranging from navigating coronary perforations, managing PCI in cardiogenic shock, and addressing rare vascular pathologies. This session offers a unique opportunity to learn from real-world experiences and expand your...

Intriguing cases in interventional cardiology

Navigating complex left main and multivessel coronary disease

05 Oct 2024 – From AICT-AsiaPCR 2024

Delve into the complexities of left main and multivessel disease in this captivating session, featuring selected AICT-AsiaPCR 2024 clinical case submissions. Witness expert cardiologists navigate intricate scenarios, from primary angioplasty of the left main with cardiogenic shock to the management of a complex left main bifurcation...

Navigating complex left main and multivessel coronary disease

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Highlights of science and education in cardiovascular interventional medicine in 2025

22 Dec 2025

Dear Colleagues, dear PCR Companions,

As we welcome a New Year, it is the perfect time to reflect on what we achieved together over the past year - both as a celebration of our collective success and as motivation to continue improving in the year ahead.

2025 was...

PCRonline: Best of science & education in 2025

World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!

29 Sep 2023

Global burden of Cardiovascular Disease

Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...

Vijay Kunadian

Author

Vijay Kunadian
World Heart Day 2023

The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030

29 Aug 2021

Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.

Vijay Kunadian

Author

Vijay Kunadian
ESC Congress 2021 - Global burden of cardiovascular disease in women; 20/20 vision for 2030: report of The Lancet commission

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
Didn’t find what you were looking for?